Telmisartan to prevent recurrent stroke and cardiovascular events (Q34596294)

3 August 2017

Telmisartan to prevent recurrent stroke and cardiovascular events (English)

1 reference

3 August 2017

1 reference

15

Björn Dahlöf

0 references

Luis Cunha

Luis Cunha

14

0 references

Jacques De Keyser

Jacques De Keyser

16

0 references

Philip M W Bath

Philip Bath

10

0 references

Geoffrey A. Donnan

Geoffrey A Donnan

17

0 references

Markku Kaste

Markku Kaste

23

0 references

Ralph L Sacco

3

Ralph L Sacco

1 reference

3 August 2017

Hans-Christoph Diener

2

Hans-Christoph Diener

1 reference

3 August 2017

1

Salim Yusuf

1 reference

ORCID Public Data File 2021

3 August 2017

0 references

0 references

1 reference

Stephanie Ounpuu

5

Stephanie Ounpuu

1 reference

3 August 2017

7

Yuko Palesch

1 reference

3 August 2017

8

Reneé H Martin

1 reference

3 August 2017

9

Gregory W Albers

1 reference

3 August 2017

11

Natan Bornstein

1 reference

3 August 2017

13

Sien-Tsong Chen

1 reference

3 August 2017

18

Conrado Estol

1 reference

3 August 2017

19

Philip Gorelick

1 reference

3 August 2017

22

Lutz Hilbrich

1 reference

3 August 2017

25

Thomas Machnig

1 reference

3 August 2017

26

Prem Pais

1 reference

3 August 2017

29

Philip Teal

1 reference

3 August 2017

30

Danilo Toni

1 reference

3 August 2017

31

Cam VanderMaelen

1 reference

3 August 2017

32

Thor Voigt

1 reference

3 August 2017

35

PRoFESS Study Group

1 reference

3 August 2017

Daniel Cotton

4

1 reference

3 August 2017

William A Lawton

6

1 reference

3 August 2017

Bernard P L Chan

12

1 reference

3 August 2017

Vivian Gu

20

1 reference

3 August 2017

Karin Hermansson

21

1 reference

3 August 2017

Chuanzhen Lu

24

1 reference

3 August 2017

Robin Roberts

27

1 reference

3 August 2017

Veronika Skvortsova

28

1 reference

3 August 2017

Michael Weber

33

1 reference

3 August 2017

Byung-Woo Yoon

34

1 reference

3 August 2017

language of work or name

English

0 references

publication date

27 August 2008

1 reference

The New England Journal of Medicine

3 August 2017

1 reference

3 August 2017

359

1 reference

3 August 2017

1225-1237

1 reference

3 August 2017

12

1 reference

Telmisartan, ramipril, or both in patients at high risk for vascular events

3 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714258

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714258

Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714258

Effect of ramipril on the incidence of diabetes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714258

Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714258

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714258

Blood pressure and clinical outcomes in the International Stroke Trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714258

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714258

Use of ramipril in preventing stroke: double blind randomised trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714258

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714258

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714258

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714258

Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714258

Characteristics of blood pressure profiles as predictors of long-term outcome after acute ischemic stroke.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714258

Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study (MOSES).

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714258

Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714258

The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714258

Ramipril and the development of diabetes.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714258

27 October 2018

Identifiers

DOI

10.1056/NEJMOA0804593

1 reference

3 August 2017

1 reference

3 August 2017

1 reference